Amarillo Biosciences announces a new clinical trial in patients with bone marrow disorders.AMARILLO, Texas--(BUSINESS WIRE)--April 24, 1997--Amarillo Biosciences Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :AMAR) announced today that a pilot study has commenced to test low dose oral interferon alpha Interferon alpha Potent immune-defense protein; used as an anti-cancer drug. Mentioned in: Waldenström's Macroglobulinemia in 30 patients with rare bone marrow proliferative disorders. Ten patients each with either agnogenic myeloid metaplasia agnogenic myeloid metaplasia Myelofibrosis with myeloid metaplasia Hematology A chronic progressive condition–panmyelosis and variable BM fibrosis, massive splenomegaly 2º to extramedullary hematopoiesis and leukoerythroblastic anemia with dysmorphic , polycythemia vera Polycythemia Vera Definition Polycythemia vera (PV) is a chronic blood disorder marked by an abnormal increase in three types of blood cells produced by bone marrow: red blood cells (RBCs), white blood cells (WBCs), and platelets. , or primary thrombocytothemia will be given low dose oral interferon alpha daily for 6-12 months as a treatment to relieve the signs and symptoms associated with these disorders. The study is being conducted at a major Midwestern medical center with a leading medical authority who specializes in the treatment of these myeloproliferative diseases. These rare myeloproliferative diseases are often difficult to treat, generally have a poor prognosis under current treatment regimes, and lead to fatal cancers. Amarillo Biosciences Inc. is one of the leading companies developing oral interferon alpha as a treatment of a variety of diseases including oral mucositis in cancer patients, hepatitis B, hepatitis C and Sjogren's Syndrome. CONTACT: Amarillo Biosciences Inc., Amarillo Charles Hughes, 806/376-1741 e-mail, amacell@arn.net or KCSA KCSA Krannert Center Student Association KCSA Kentucky Crushed Stone Association (Frankfort, KY) KCSA Kyiv City State Administration KCSA Kalamazoo Christian School Association KCSA Kentucky-Canadian Studies Association , New York Leslie A. Schupak or Joseph A. Mansi, 212/682-6300, ext. 207/205 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion